CICCONE, Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.153
EU - Europa 832
AS - Asia 527
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 4.517
Nazione #
US - Stati Uniti d'America 3.149
CN - Cina 380
DE - Germania 207
UA - Ucraina 194
IT - Italia 136
TR - Turchia 129
GB - Regno Unito 99
SE - Svezia 55
FI - Finlandia 47
FR - Francia 47
RU - Federazione Russa 22
BE - Belgio 14
IR - Iran 4
CA - Canada 3
IN - India 3
JP - Giappone 3
NL - Olanda 3
PL - Polonia 3
AU - Australia 2
ES - Italia 2
KR - Corea 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EU - Europa 1
HK - Hong Kong 1
IE - Irlanda 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
RW - Ruanda 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 4.517
Città #
Woodbridge 476
Fairfield 392
Houston 309
Chandler 263
Jacksonville 224
Ann Arbor 179
Ashburn 165
Seattle 157
Cambridge 147
Wilmington 137
Beijing 123
Nanjing 71
Izmir 68
New York 54
Princeton 54
Ferrara 47
Shanghai 41
San Diego 40
Addison 38
Boardman 38
Milan 33
Shenyang 26
Bremen 25
Nanchang 21
Hebei 15
Brussels 14
Changsha 12
Jinan 11
Tianjin 11
Auburn Hills 10
Augusta 10
Los Angeles 9
Dearborn 8
Orange 8
San Jose 8
Jiaxing 7
San Mateo 7
Zhengzhou 6
Falls Church 5
Guangzhou 5
Hefei 5
Mountain View 5
Norwalk 5
Redwood City 5
Washington 5
Leawood 4
London 4
Minerbe 4
Philadelphia 4
Redmond 4
Bologna 3
Changchun 3
Illasi 3
Lagopesole 3
Lanzhou 3
Rome 3
Tappahannock 3
Verona 3
Ardabil 2
Chengdu 2
Chicago 2
Des Moines 2
Dong Ket 2
Frankfurt am Main 2
Fuzhou 2
Haikou 2
Hangzhou 2
Hounslow 2
Indiana 2
Kunming 2
Madrid 2
Monmouth Junction 2
Ningbo 2
Sabz 2
San Francisco 2
Taiyuan 2
Taizhou 2
Warsaw 2
Yellow Springs 2
Acton 1
Aguascalientes 1
Andover 1
Andria 1
Calgary 1
Canberra 1
Central 1
Chiswick 1
Clearwater 1
Dublin 1
Helsinki 1
Johor Bahru 1
Melbourne 1
Miami 1
Mumbai 1
Neath 1
New Bedfont 1
Pavullo Nel Frignano 1
Pescara 1
Pisa 1
San Giorgio Di Piano 1
Totale 3.406
Nome #
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 152
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 148
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 131
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 130
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 130
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 128
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 124
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 122
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 116
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 116
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 115
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 108
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 108
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 106
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 105
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 105
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 105
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 103
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 103
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 100
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 100
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 97
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 97
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 97
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 97
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 94
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 92
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 90
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 87
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 86
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 84
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 83
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 83
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 77
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 72
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 72
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 67
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 66
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 65
Neoplastic circulating endothelial cells in hematologic malignancies 63
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 61
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 60
Molecular cytogenetic lesions in chronic lymphocytic leukemia 59
null 59
null 55
null 45
Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia. 45
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 15
Neoplastic circulating endothelial cells in hematologic malignancies 13
Neoplastic circulating endothelial cells in hematologic malignancies. 11
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 7
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 6
Totale 4.584
Categoria #
all - tutte 16.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 265
Totale 16.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019323 0 0 0 0 0 0 0 0 0 0 117 206
2019/20201.024 164 30 28 145 68 116 97 97 81 120 59 19
2020/2021706 53 54 37 82 22 85 22 75 7 86 127 56
2021/2022585 57 69 32 17 29 23 24 18 11 46 57 202
2022/2023573 57 31 24 70 112 76 31 56 63 5 26 22
2023/2024204 28 39 10 7 11 56 12 23 7 6 5 0
Totale 4.584